[Peyronie's disease. Evaluation of 3 therapeutic modalities: propoleum, laser and simultaneous propoleum-laser].

Objectives: To compare the results of treatment of peyronie's disease with propoleum, laser, and simultaneous propoleum-laser.

Methods: Prospective research. Twenty-eight patients with Peyronie's disease from the hospitals Freyre de Andrade,Fajardo, Clinico Quirúrgico y Habana Campo were studied between May 2002 and August 2003.

[Study of propoleum dosage in Peyronie's disease].

Objectives: To determine the optimal dose for propoleum caps in Peyronie's disease.

Methods: We evaluated two groups of 17 patients each, analyzing pain and plaque size on physical and ultrasound examination, before and after treatment. Group A patients received caps with 300 mg of propoleum powder daily for six months, and Group B 900 mg.